By Marcia Dunn

Spacewalking astronauts ventured out Sunday to install support frames for new, high-efficiency solar panels arriving at the International Space Station later this year.

NASA's Kate Rubins and Victor Glover put the first set of mounting brackets and struts together, then bolted them into place next to the station's oldest and most degraded solar wings. But the work took longer than expected, and they barely got started on the second set before calling it quits.

Rubins will finish the job during a second spacewalk later this week.

The spacewalkers had to lug out the hundreds of pounds of mounting brackets and struts in 8-foot (2.5-meter) duffle-style bags. The equipment was so big and awkward that it had to be taken apart like furniture, just to get through the hatch.

Some of the attachment locations required extra turns of the power drill and still weren't snug enough, as indicated by black lines. The astronauts had to use a ratchet wrench to deal with the more stubborn bolts, which slowed them down. At one point, they were two hours behind.

“Whoever painted this black line painted outside the lines a little bit," Glover said at one particularly troublesome spot.

“We’ll work on our kindergarten skills over here,” Mission Control replied, urging him to move on.

With more people and experiments flying on the space station, more power will be needed to keep everything running, according to NASA. The six new solar panels — to be delivered in pairs by SpaceX over the coming year or so — should boost the station’s electrical capability by as much as 30%.

Rubins and Glover tackled the struts for the first two solar panels, due to launch in June. Their spacewalk ended up lasting seven hours, a bit longer than planned.

“Really appreciate your hard work. I know there were a lot of challenges,” Mission Control radioed.

The eight solar panels up there now are 12 to 20 years old — most of them past their design lifetime and deteriorating. Each panel is 112 feet (34 meters) long by 39 feet (12 meters) wide. Tip to tip counting the center framework, each pair stretches 240 feet (73 meters), longer than a Boeing 777′s wingspan.

Boeing is supplying the new roll-up panels, about half the size of the old ones but just as powerful thanks to the latest solar cell technology. They’ll be placed at an angle above the old ones, which will continue to operate.

A prototype was tested at the space station in 2017.

Rubins' helmet featured a new high-definition camera that provided stunning views, particularly those showing the vivid blue Earth 270 miles (435 kilometers) below. “Pretty fantastic," observed Mission Control.

Sunday’s spacewalk was the third for infectious disease specialist Rubins and Navy pilot Glover — both of whom could end up flying to the moon.

They’re among 18 astronauts newly assigned to NASA’s Artemis moon-landing program. The next moonwalkers will come from this group.

Last week, Vice President Kamala Harris put in a congratulatory call to Glover, the first African American astronaut to live full time at the space station. NASA released the video exchange Saturday.

“The history making that you are doing, we are so proud of you,” Harris said. Like other firsts, Glover replied, it won't be the last. “We want to make sure that we can continue to do new things,” he said.

Rubins will float back out Friday with Japanese astronaut Soichi Noguchi to wrap up the solar panel prep work, and to vent and relocate ammonia coolant hoses.

Glover and Noguchi were among four astronauts arriving via SpaceX in November. Rubins launched from Kazakhstan in October alongside two Russians. They’re all scheduled to return to Earth this spring.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
As U.S. Opioid Crisis Worsens, Price of Life-Saving Drug Naloxone Skyrockets
Jill Wagner and Baker Machado break down the state of the Opioid Crisis in the U.S. The CDC reported a 30% increase in overdose deaths from 2020 to 2021, but in recent months pharmaceutical companies have drastically raised the price of Naloxone or 'Narcan,' affecting the response of community harm prevention groups.
Regeneron Joins Battle Against COVID-19, Releases Stats on New COVID Treatment
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Legal Questions Swirl as States Push Back Against Biden COVID Vaccine Mandate
The Biden Administration's mandate for COVID vaccinations by large employers has been put on hold by federal courts as GOP-led states and some businesses push back on the order's legality. Jonathan Adler, a law professor at Case Western Reserve University, joined Cheddar to discuss the legal challenges to implementing such mandates through OSHA (Occupational Safety and Health Administration). "Certainly expanding vaccinations is a good thing, and as vaccination rates go up that's better for all of us," Adler said. "But there are some legal questions about whether or not it's appropriate to use a law about occupational safety and health as the means to do that."
What COVID-19 Vaccines for Kids Might Mean for Fight Against Pandemic
Dr. Robert Frenck, an infectious disease specialist at Cincinnati Children's Hospital, joined Cheddar to talk about the significance of children ages 5-11 being authorized to receive COVID-19 vaccinations. He also discussed schools being cleared to administer vaccines and noted the importance of meeting people where they are rather than forcing them to find the shots. Frenck also said he expects that children under 5 years old will begin getting vaccinations sometime in spring.
Everything You Need to Know About Child Covid-19 Vaccines
A CDC advisory committee as unanimously voted to recommend the Pfizer Covid-19 vaccine in children ages 5 to 11. Dr. Amesh Adalja, Infectious Disease Specialist and Senior Scholar at Johns Hopkins Center for Health Security, joined Cheddar News to discuss.
Load More